Hospital de Clínicas de Porto Alegre (HCPA)
Hospital
Location:
Porto Alegre,
Brazil (BR)
ISNI: 0000000101253761
ROR: https://ror.org/010we4y38
RHABDOID TUMOR PREDISPOSITION SYNDROME (RTPS) - FINDING EVIDENCE BY SYSTEMATIC ANALYSES (2022)
Nemes K, Bens S, Johann PD, Steinbuegl M, Gruhle M, Kachanov D, Teleshova M, et al.
Conference contribution
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis (2021)
Efe C, Lammert C, Tascilar K, Dhanasekaran R, Ebik B, Higuera-De La Tijera F, Caliskan AR, et al.
Journal article
Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study (2015)
Huizinga TWJ, Conaghan PG, Martin-Mola E, Schett G, Amital H, Xavier RM, Troum O, et al.
Journal article
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study (2014)
Dougados M, Kissel K, Conaghan PG, Mola EM, Schett G, Gerli R, Hansen MS, et al.
Journal article